Sector revisions Cybin Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:00 2025-06-17 pm EDT			5-day change	1st Jan Change
7.710 ^USD	-4.10%		-8.76%	-12.59%

Jun. 13	Cybin Inc. Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics	CI
Jun. 13	Cybin Provides Corporate Update, Highlights Positive Regulatory Signals For Psychedelic Therapeutics	RE

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. Revenue rev.	1y. Revenue rev.	Nbr of analysts
CYBIN INC.	-	-	-	5
REGENERON PHARMACEUTICALS, INC.				24
ARGENX SE				16
BEONE MEDICINES LTD.				24
WUXI APPTEC CO., LTD.				18
BIONTECH SE				21
INSMED INCORPORATED				18
SUMMIT THERAPEUTICS INC.				9
GENMAB A/S				16
WUXI BIOLOGICS (CAYMAN) INC.				26
EXELIXIS, INC.				19
AKESO, INC.				20
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.				15
VERONA PHARMA PLC				10
LEGEND BIOTECH CORPORATION				21
MADRIGAL PHARMACEUTICALS, INC.				14
PHARMAESSENTIA CORPORATION				4
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.				2
NUVALENT, INC.				9
Average				15
Weighted average by Cap.				19